Consequences of Abrupt Cessation of Alpha1-Antitrypsin Replacement Therapy

N Engl J Med. 2020 Apr 9;382(15):1478-1480. doi: 10.1056/NEJMc1915484.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cost Sharing
  • Drug Industry
  • Financing, Government*
  • Health Policy
  • Humans
  • Ireland
  • Pulmonary Disease, Chronic Obstructive / etiology
  • Withholding Treatment*
  • alpha 1-Antitrypsin / economics
  • alpha 1-Antitrypsin / therapeutic use*
  • alpha 1-Antitrypsin Deficiency / complications
  • alpha 1-Antitrypsin Deficiency / drug therapy*
  • alpha 1-Antitrypsin Deficiency / mortality

Substances

  • alpha 1-Antitrypsin